News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
716,370 Results
Type
Article (40896)
Company Profile (293)
Press Release (675174)
Multimedia
Podcasts (80)
Webinars (17)
Section
Business (205436)
Career Advice (2030)
Deals (35603)
Drug Delivery (102)
Drug Development (81462)
Employer Resources (173)
FDA (16351)
Job Trends (14978)
News (347268)
Policy (32795)
Tag
Academia (2576)
Accelerated approval (15)
Adcomms (24)
Allergies (116)
Alliances (49920)
ALS (134)
Alzheimer's disease (1565)
Antibody-drug conjugate (ADC) (225)
Approvals (16452)
Artificial intelligence (400)
Autoimmune disease (83)
Automation (29)
Bankruptcy (364)
Best Places to Work (11658)
BIOSECURE Act (21)
Biosimilars (152)
Biotechnology (190)
Bladder cancer (132)
Brain cancer (45)
Breast cancer (490)
Cancer (3841)
Cardiovascular disease (310)
Career advice (1711)
Career pathing (33)
CAR-T (228)
CDC (43)
Cell therapy (614)
Cervical cancer (31)
Clinical research (68345)
Collaboration (1326)
Company closure (4)
Compensation (919)
Complete response letters (44)
COVID-19 (2695)
CRISPR (74)
C-suite (569)
Cystic fibrosis (131)
Data (4651)
Decentralized trials (2)
Denatured (28)
Depression (96)
Diabetes (423)
Diagnostics (6560)
Digital health (33)
Diversity (11)
Diversity, equity & inclusion (45)
Drug discovery (187)
Drug pricing (160)
Drug shortages (28)
Duchenne muscular dystrophy (192)
Earnings (89079)
Editorial (46)
Employer branding (21)
Employer resources (151)
Events (115967)
Executive appointments (934)
FDA (18808)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (15)
Funding (1205)
Gene editing (161)
Generative AI (31)
Gene therapy (484)
GLP-1 (875)
Government (4619)
Grass and pollen (6)
Guidances (368)
Healthcare (18875)
HIV (43)
Huntington's disease (37)
IgA nephropathy (59)
Immunology and inflammation (215)
Immuno-oncology (18)
Indications (57)
Infectious disease (2920)
Inflammatory bowel disease (177)
Inflation Reduction Act (15)
Influenza (93)
Intellectual property (189)
Interviews (315)
IPO (16645)
IRA (50)
Job creations (3674)
Job search strategy (1439)
Kidney cancer (15)
Labor market (73)
Layoffs (542)
Leadership (28)
Legal (7973)
Liver cancer (85)
Longevity (11)
Lung cancer (552)
Lymphoma (262)
Machine learning (29)
Management (59)
Manufacturing (595)
MASH (134)
Medical device (13638)
Medtech (13662)
Mergers & acquisitions (19839)
Metabolic disorders (1041)
Multiple sclerosis (133)
NASH (16)
Neurodegenerative disease (202)
Neuropsychiatric disorders (50)
Neuroscience (2527)
NextGen: Class of 2025 (6552)
Non-profit (4504)
Now hiring (59)
Obesity (487)
Opinion (243)
Ovarian cancer (137)
Pain (154)
Pancreatic cancer (170)
Parkinson's disease (226)
Partnered (28)
Patents (405)
Patient recruitment (320)
Peanut (52)
People (58592)
Pharmaceutical (67)
Pharmacy benefit managers (25)
Phase I (21289)
Phase II (30077)
Phase III (22428)
Pipeline (2730)
Policy (250)
Postmarket research (2565)
Preclinical (9079)
Press Release (64)
Prostate cancer (191)
Psychedelics (42)
Radiopharmaceuticals (256)
Rare diseases (611)
Real estate (5982)
Recruiting (69)
Regulatory (23570)
Reports (51)
Research institute (2359)
Resumes & cover letters (352)
Rett syndrome (15)
RNA editing (14)
RSV (67)
Schizophrenia (126)
Series A (200)
Series B (150)
Service/supplier (13)
Sickle cell disease (74)
Special edition (20)
Spinal muscular atrophy (149)
Sponsored (36)
Startups (3655)
State (2)
Stomach cancer (14)
Supply chain (94)
Tariffs (80)
The Weekly (50)
Vaccines (911)
Venture capital (65)
Weight loss (318)
Women's health (55)
Worklife (17)
Date
Today (39)
Last 7 days (660)
Last 30 days (2520)
Last 365 days (30563)
2025 (25408)
2024 (35331)
2023 (40179)
2022 (51288)
2021 (55834)
2020 (54153)
2019 (46641)
2018 (35123)
2017 (32221)
2016 (31629)
2015 (37707)
2014 (31455)
2013 (26499)
2012 (28770)
2011 (29427)
2010 (27525)
Location
Africa (732)
Alabama (71)
Alaska (7)
Arizona (270)
Arkansas (13)
Asia (38907)
Australia (6372)
California (9365)
Canada (2845)
China (863)
Colorado (391)
Connecticut (397)
Delaware (262)
Europe (83866)
Florida (1394)
Georgia (302)
Hawaii (2)
Idaho (61)
Illinois (721)
India (49)
Indiana (452)
Iowa (18)
Japan (322)
Kansas (121)
Kentucky (34)
Louisiana (18)
Maine (68)
Maryland (1220)
Massachusetts (6810)
Michigan (283)
Minnesota (540)
Mississippi (4)
Missouri (111)
Montana (29)
Nebraska (25)
Nevada (103)
New Hampshire (73)
New Jersey (2569)
New Mexico (28)
New York (2524)
North Carolina (1255)
North Dakota (8)
Northern California (4368)
Ohio (287)
Oklahoma (20)
Oregon (38)
Pennsylvania (1962)
Puerto Rico (19)
Rhode Island (43)
South America (1102)
South Carolina (49)
South Dakota (1)
Southern California (3601)
Tennessee (148)
Texas (1449)
United States (33850)
Utah (278)
Virginia (223)
Washington D.C. (78)
Washington State (778)
West Virginia (4)
Wisconsin (79)
Wyoming (2)
716,370 Results for "mbx biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MBX Biosciences to Participate in November 2025 Investor Conferences
October 21, 2025
·
2 min read
Press Releases
MBX Biosciences Announces Proposed Public Offering
September 23, 2025
·
4 min read
Press Releases
MBX Biosciences Announces Pricing of Upsized Public Offering
September 24, 2025
·
4 min read
Press Releases
MBX Biosciences to Participate in the Stifel 2025 Virtual Cardiometabolic Forum
September 30, 2025
·
1 min read
Press Releases
MBX Biosciences Doses First Participant in Phase 1 Trial of MBX 4291 for the Treatment of Obesity
September 5, 2025
·
7 min read
Press Releases
MBX Biosciences Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights
August 8, 2025
·
9 min read
Press Releases
MBX Biosciences to Provide Topline Results from its Phase 2 Trial of Potential Once-Weekly Canvuparatide for Hypoparathyroidism (HP) on Monday, September 22
September 22, 2025
·
1 min read
Press Releases
MBX Biosciences to Participate in June Investor Conferences
May 20, 2025
·
1 min read
Press Releases
MBX Biosciences Announces IND Submission of MBX 4291, its Long-acting GLP1/GIP Receptor Co-agonist Prodrug for the Treatment of Obesity
June 16, 2025
·
6 min read
Press Releases
MBX Biosciences Announces Once-Weekly Canvuparatide Achieved Primary Endpoint in Phase 2 Trial with 63% Responder Rate at 12 Weeks; 79% Responder Rate at 6 Months in Open-Label Extension
September 23, 2025
·
10 min read
1 of 71,637
Next
